Global Breast Biopsy Device Market,Impressive CAGR of 5.5% by 2027-Global Demand Analysis & Opportunity Outlook 2027
“Breast Biopsy Device Market: Global Demand Analysis & Opportunity Outlook 2027”
The global breast biopsy device market is segmented by biopsy component type into vacuum assisted biopsy (VAB), core needle biopsy (CNB) and fine needle aspiration biopsy (FNAB); by guiding technology into MRI-guided biopsy, ultrasound guided biopsy, mammography guided stereotactic biopsy, CT-guided biopsy and others; by end-users into hospitals, ambulatory surgical centers, clinics, cancer research organizations and others and by regions. Breast Biopsy Device Market is anticipated to mask a CAGR of 5.5% during the forecast period i.e. 2019-2027.
The global breast biopsy device market is observing vibrant growth on the back of increasing demand of diagnostic procedures for scaling, or crusting of the breast skin. Advancements in healthcare industry in the past few years and growing breast cancer incidences is projected to drive breast biopsy device market besides the wide range of functions of breast biopsy device in detection of abnormal changes in the nipple for instance, cellulite and congealing during the forecast period.
Being a developed region with excellent healthcare facilities, North America is panned to observe significant growth in breast biopsy device market on the back of rising breast biopsy device usage for detecting cellulite and surgical cysts in women. North America is estimated to be followed by Asia Pacific in terms of usage due to expanding breast biopsy device requirements in growing female cancer population across the region. Europe is expected to drive demand and positively impact breast biopsy device market growth over the forecast period owing to increasing geriatric female population suffering from breast cancer across the region.
Growing Applications due to Rising Incidences of Breast Cancer
On the back of rising incidences of cancer in the global population, the breast biopsy device market is anticipated to increase over the forecast period. World Health Organization reports breast cancer as one of the leading causes of deaths in cancer patients. The cause behind breast cancer can be attributed to various factors such as, increasing alcohol consumption in women, rising female smocking population, with growing adoption of sedentary lifestyle and unhealthy eating across the globe. Additionally, the number of incidences of cancer is anticipated to increase on the back of rise in mutational changes in the human body along with increasing exposure of skin to ultra-violet rays.
However, lack of awareness in the female population regarding biopsy procedures and presence of sub-standard healthcare facilities results in 70% of cancer deaths approximately, in low- and middle-income countries, which is expected to hinder the steady growth of the breast biopsy devices market over the forecast period around the under-developed and some developing regions across the globe.
The report titled “Global Breast Biopsy Device Market: Global Demand Analysis & Opportunity Outlook 2027” delivers detailed overview of the global breast biopsy device market in terms of market segmentation by biopsy component type, by guiding technology, by end-users and by regions.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
This report also provides the existing competitive scenario of some of the key players of the global breast biopsy device market which includes company profiling of Leica Biosystems Nussloch GmbH, Hologic Inc., C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC., Ethicon Endo Surgery (Johnson & Johnson), Intact Medical Corporation, Galini SRL and Other Prominent Players. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global Breast Biopsy Device market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
About Research Nester:
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Contact for more Info:
Ajay Daniel
Email: ajay.daniel@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
